Researched and written by ChatGPT
Walmart has agreed to pay $50 million to settle a U.S. Department of Justice lawsuit alleging its pharmacies illegally filled thousands of opioid and other controlled-substance prescriptions.
And the details are ugly.
According to the DOJ, Walmart’s own pharmacists repeatedly warned the company about doctors they believed were operating as “pill mills.” Those warnings included thousands of refusal-to-fill reports. Yet the government alleged that Walmart’s corporate compliance team continued allowing prescriptions from some of those prescribers to be filled.
The DOJ says pharmacists encountered glaring red flags: dangerous drug combinations, repeated high-dose opioid prescriptions, early refill requests and prescriptions written by already-suspect doctors. The original 2020 lawsuit alleged Walmart’s conduct contributed to the opioid epidemic and involved hundreds of thousands of Controlled Substances Act violations.
Perhaps the most revealing detail comes from an internal email quoted by the government. Rather than spending management time analyzing pharmacists’ refusal reports, a Walmart compliance director reportedly described “driving sales and patient awareness” as a better use of their time.
On August 28, 2026, Walmart settled the federal case for $50 million without admitting liability. It must also strengthen monitoring of controlled-substance dispensing and establish a hotline for reporting suspected illegal dispensing.
And this isn’t Walmart’s first enormous opioid settlement. In 2022, the company agreed to pay roughly $3.1 billion to resolve opioid claims brought by states and local governments.
For years we were told the opioid catastrophe was about irresponsible patients, crooked doctors and street dealers.
Turns out there were some very large corporate cash registers in the middle of it too.
No comments:
Post a Comment